Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Bristol-Myers Squibb

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.

Bristol-Myers Squibb

Lilly’s pegilodecakin fails in long-shot pancreatic cancer trial

Lilly’s pegilodecakin fails in long-shot pancreatic cancer trial

market, latterly eclipsed by the stellar growth of checkpoint inhibitors from the likes of Merck &Co/MSD and Bristol-Myers Squibb.

Bayer/J&J claim new FDA okay for clot drug Xarelto

Bayer/J&J claim new FDA okay for clot drug Xarelto The new indication gives Xarelto a leg up over other drugs in the novel oral anticoagulant (NOAC) class, which include Pfizer/Bristol-Myers Squibb’s Eliquis (apixaban), Boehringer Ingelheim’s Pradaxa

Allergan investors back AbbVie deal, but is a tax charge looming?

Allergan investors back AbbVie deal, but is a tax charge looming? Therapeutics and Bristol-Myers Squibb’s forced divestiture of psoriasis drug Otezla (apremilast) in order to get its $74bn acquisition of Celgene over the line.

Innate Pharma and AstraZeneca take monalizumab into phase 3

Innate Pharma and AstraZeneca take monalizumab into phase 3 AZ has been seeking Imfinzi combinations which could help it gain on earlier-to-market rivals in the checkpoint inhibitor category, including Merck &Co’s Keytruda and Bristol-Myers Squibb’s

France’s Innate Pharma eyes $100m Nasdaq IPO

France’s Innate Pharma eyes $100m Nasdaq IPO Bristol-Myers Squibb's Opdivo, but its first efforts – centred on CTLA4 inhibitor tremelimumab – have ended in failure.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics